Your browser doesn't support javascript.
loading
The GR-ANXA1 pathway is a pathological player and a candidate target in epilepsy.
Zub, Emma; Canet, Geoffrey; Garbelli, Rita; Blaquiere, Marine; Rossini, Laura; Pastori, Chiara; Sheikh, Madeeha; Reutelingsperger, Chris; Klement, Wendy; de Bock, Frederic; Audinat, Etienne; Givalois, Laurent; Solito, Egle; Marchi, Nicola.
Affiliation
  • Zub E; Laboratory of Cerebrovascular and Glia Research, Department of Neuroscience, Institute of Functional Genomics, Unité Mixtes de Recherche (UMR) 5203 Centre National de la Recherche Scientifique (CNRS)-Unité 1191 INSERM, University of Montpellier, Montpellier, France.
  • Canet G; Molecular Mechanisms in Neurodegenerative Diseases, INSERM Unite 1198, University of Montpellier, Montpellier, France.
  • Garbelli R; Epilepsy Unit, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Neurologico Carlo Besta, Milan, Italy.
  • Blaquiere M; Laboratory of Cerebrovascular and Glia Research, Department of Neuroscience, Institute of Functional Genomics, Unité Mixtes de Recherche (UMR) 5203 Centre National de la Recherche Scientifique (CNRS)-Unité 1191 INSERM, University of Montpellier, Montpellier, France.
  • Rossini L; Epilepsy Unit, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Neurologico Carlo Besta, Milan, Italy.
  • Pastori C; Epilepsy Unit, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Neurologico Carlo Besta, Milan, Italy.
  • Sheikh M; William Harvey Research Institute, Barts and The London, Queen Mary's School of Medicine and Dentistry, London, United Kingdom.
  • Reutelingsperger C; Department of Biochemistry, Cardiovascular Research Institute, Maastricht University, Maastricht, The Netherlands.
  • Klement W; Laboratory of Cerebrovascular and Glia Research, Department of Neuroscience, Institute of Functional Genomics, Unité Mixtes de Recherche (UMR) 5203 Centre National de la Recherche Scientifique (CNRS)-Unité 1191 INSERM, University of Montpellier, Montpellier, France.
  • de Bock F; Laboratory of Cerebrovascular and Glia Research, Department of Neuroscience, Institute of Functional Genomics, Unité Mixtes de Recherche (UMR) 5203 Centre National de la Recherche Scientifique (CNRS)-Unité 1191 INSERM, University of Montpellier, Montpellier, France.
  • Audinat E; Laboratory of Cerebrovascular and Glia Research, Department of Neuroscience, Institute of Functional Genomics, Unité Mixtes de Recherche (UMR) 5203 Centre National de la Recherche Scientifique (CNRS)-Unité 1191 INSERM, University of Montpellier, Montpellier, France.
  • Givalois L; Molecular Mechanisms in Neurodegenerative Diseases, INSERM Unite 1198, University of Montpellier, Montpellier, France.
  • Solito E; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, Italy.
  • Marchi N; Laboratory of Cerebrovascular and Glia Research, Department of Neuroscience, Institute of Functional Genomics, Unité Mixtes de Recherche (UMR) 5203 Centre National de la Recherche Scientifique (CNRS)-Unité 1191 INSERM, University of Montpellier, Montpellier, France.
FASEB J ; 33(12): 13998-14009, 2019 12.
Article in En | MEDLINE | ID: mdl-31618599
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Glucocorticoid / Annexin A1 / Epilepsy Limits: Animals / Humans Language: En Journal: FASEB J Journal subject: BIOLOGIA / FISIOLOGIA Year: 2019 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Glucocorticoid / Annexin A1 / Epilepsy Limits: Animals / Humans Language: En Journal: FASEB J Journal subject: BIOLOGIA / FISIOLOGIA Year: 2019 Type: Article Affiliation country: France